COVID-19 and the failure of pharmaceutical innovation for the global South : the example of "neglected diseases" and emerging infectious diseases
Year of publication: |
March 2021
|
---|---|
Authors: | Raza, Werner G. |
Publisher: |
Vienna : Austrian Foundation for Development Research - ÖFSE |
Subject: | TRIPS-agreement | COVID-19 | neglected diseases | new infectious diseases | patents | Infektionskrankheit | Infectious disease | Coronavirus | Gesundheitspolitik | Health policy | Entwicklungsländer | Developing countries | Patent | Epidemie | Epidemic | Innovation | Arzneimittel | Pharmaceuticals | Welt | World | Krankheit | Disease | Pharmakologie | Pharmacology |
Extent: | 1 Online-Ressource (circa 17 Seiten) Illustrationen |
---|---|
Series: | Briefing papers / Österreichische Forschungsstiftung für Internationale Entwicklung. - Wien : ÖFSE, ZDB-ID 2778303-0. - Vol. 32 |
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Graue Literatur ; Non-commercial literature |
Language: | English |
Other identifiers: | hdl:10419/232582 [Handle] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Equitable access to COVID-19 related health technologies : a global priority
Boru, Zeleke Temesgen, (2020)
-
The TRIPS waiver proposal: an urgent measure to expand access to the COVID-19 vaccines
Menezes, Henrique Zeferino de, (2021)
-
COVID-19 vaccines as global public goods : between life and profit
King, Katiuska, (2022)
- More ...
-
Raza, Werner G., (1999)
-
Raza, Werner G., (2000)
-
Becker, Joachim, (1999)
- More ...